{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:39:49Z","timestamp":1788921589213,"version":"build-2803163510"},"reference-count":19,"publisher":"S. Karger AG","issue":"5","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/karger.com\/pages\/terms-and-conditions"},{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/karger.com\/pages\/terms-and-conditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Nephrol"],"abstract":"<jats:p>Introduction: The pharmacokinetic data on dapagliflozin, a sodium-glucose cotransporter-2 inhibitor, are limited in patients with severe renal impairment. We aimed to evaluate the pharmacokinetic properties and safety of dapagliflozin in patients with chronic kidney disease (CKD) stage 4. Methods: This was a single-center, open-label, pharmacokinetic trial involving single, and multiple doses. Patients with an estimated glomerular filtration rate (eGFR) of 15-&lt;30 mL\/min\/1.73 m2 were enrolled. The single-dose group received 10 mg of oral dapagliflozin once daily, while the multiple-dose group received 10 mg daily for 5 days. Pharmacokinetic parameters, pharmacodynamic response, and tolerability were assessed. Results: A total of 12 participants completed the single-dose study, and 9 participants completed the multiple-dose study. The mean eGFR was 23.4 and 23.2 mL\/min\/1.73 m2 in single- and multiple-dose group, respectively. In the single-dose group, dapagliflozin was rapidly absorbed and metabolized to produce dapagliflozin 3-O-glucuronide (D3OG), with a mean T&lt;sub&gt;max&lt;\/sub&gt; of 0.7 h and 1.8 h, and a mean T&lt;sub&gt;1\/2&lt;\/sub&gt; of 16.7 h and 14.9 h, respectively. Participants with an eGFR of 15\u201324 mL\/min\/1.73 m2 exhibited higher AUC&lt;sub&gt;0-\u221e&lt;\/sub&gt; and mean residence time for D3OG compared to those with an eGFR of 25\u201330 mL\/min\/1.73 m2. In the multiple-dose group, there was no significant accumulation of dapagliflozin, as indicated by the ratio of AUC&lt;sub&gt;Tau&lt;\/sub&gt; (918.6 \u00b1 155.2 h \u00d7 ng\/mL) to AUC&lt;sub&gt;0\u201324 h&lt;\/sub&gt; (917.1 \u00b1 154.7 h \u00d7 ng\/mL) was close to 1. In the multiple-dose group, urinary albumin\/creatinine ratio decreased by 21% and 24-h urinary protein decreased by 23% from baseline to 24 h after the last dose. Conclusion: In conclusion, no clinically significant accumulation of dapagliflozin was observed in patients with stage 4 CKD. <\/jats:p>","DOI":"10.1159\/000544936","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T13:01:17Z","timestamp":1741957277000},"page":"618-629","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacokinetic Properties of Dapagliflozin in Patients with Stage 4 Chronic Kidney Disease"],"prefix":"10.1159","volume":"56","author":[{"given":"Dan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ancheng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaya","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2905-936X","authenticated-orcid":false,"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianxiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanwen","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yerong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0613-2077","authenticated-orcid":false,"given":"Min","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"127","published-online":{"date-parts":[[2025,3,14]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024816"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2204233"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.0000000000000221"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2021020167"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfac044"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7326\/M23-1874"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-019-01148-3"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-020-00956-1"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2014.873788"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.109.029165"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12056"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2013.06.017"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2011.01359.x"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2012.04391.x"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2011.01397.x"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2102953"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.2196"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.10.018"}],"container-title":["American Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/karger.com\/ajn\/article-pdf\/doi\/10.1159\/000544936\/4351887\/000544936.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/karger.com\/article-pdf\/doi\/10.1159\/000544936","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T16:02:25Z","timestamp":1759766545000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000544936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":19,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,10,6]]},"published-print":{"date-parts":[[2025,10,8]]}},"URL":"https:\/\/doi.org\/10.1159\/000544936","archive":["Portico"],"relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.6084\/m9.figshare.28596149","asserted-by":"subject"}]},"ISSN":["0250-8095","1421-9670"],"issn-type":[{"value":"0250-8095","type":"print"},{"value":"1421-9670","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]}}}